Movement Disorders, 0885-3185

Journal

More filtering options
  1. 2019
  2. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease

    EUROPAR, Dafsari, H. S., Martinez-Martin, P., Rizos, A., Trost, M., dos Santos Ghilardi, M. G., Reddy, P., Sauerbier, A., Petry-Schmelzer, J. N., Kramberger, M., Borgemeester, R. W. K., Barbe, M. T., Ashkan, K., Silverdale, M., Evans, J., Odin, P., Fonoff, E. T., Fink, G. R., Henriksen, T., Ebersbach, G. & 5 othersPirtošek, Z., Visser-Vandewalle, V., Antonini, A., Timmermann, L. & Ray Chaudhuri, K., 2019 Feb 4, In : Movement Disorders.

    Research output: Contribution to journalArticle

  3. 2018
  4. Animal models of l-dopa-induced dyskinesia in Parkinson's disease

    M. Angela Cenci & Crossman, A. R., 2018 Jun 1, In : Movement Disorders. 33, 6, p. 889-899

    Research output: Contribution to journalReview article

  5. 11C-PE2I and 18F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study

    Li, W., Lao-Kaim, N. P., Roussakis, A. A., Marti´n-Bastida, A., Valle-Guzman, N., Gesine Paul, Loane, C., Håkan Widner, Politis, M., Foltynie, T., Barker, R. A. & Piccini, P., 2018 Jan, In : Movement Disorders. 33, 1, p. 117-127

    Research output: Contribution to journalArticle

  6. 2017
  7. Which ante mortem clinical features predict progressive supranuclear palsy pathology?

    for the Movement Disorder Society-Endorsed PSP Study Group, Elisabet Englund & Nilsson, C., 2017 Jul 1, In : Movement Disorders. 32, 7, p. 995-1005 11 p.

    Research output: Contribution to journalReview article

  8. PBB3 Imaging in Parkinsonian disorders: Evidence for binding to abnormally aggregated proteins in addition to tau proteins

    Perez-Soriano, A., Arena, J. E., Sossi, V., Dinelle, K., Miao, Q., McKenzie, C. J., Neilson, N., A. Puschmann, Schaffer, P., Shinotoh, H., Smith-Forrester, J., Shahinfard, E., Vafai, N., Wile, D., Wszolek, Z. K., Higuchi, M. & Stoessl, A. J., 2017 Jun 1, In : Movement Disorders. 32, Suppl 2, p. 585-587

    Research output: Contribution to journalPublished meeting abstract

  9. Factors associated with perceived walking difficulties in people with Parkinson’s disease

    Kader, M., Ullén, S., Susanne Iwarsson, Per Odin & Maria Nilsson, 2017 Jun, In : Movement Disorders. 32, Suppl. 2, 1374.

    Research output: Contribution to journalPublished meeting abstract

  10. Increased basal ganglia binding of 18F-AV-1451 in patients with progressive supranuclear palsy

    Ruben Smith, Schain, M., Nilsson, C., Olof Strandberg, Olsson, T., Douglas Hägerström, Jonas Jögi, Borroni, E., Michael Schöll, Honer, M. & Oskar Hansson, 2017 Jan, In : Movement Disorders. 32, 1, p. 108-114

    Research output: Contribution to journalArticle

  11. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

    Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., Mollenhauer, B., Müller, U., Nilsson, C., Whitwell, J. L., Arzberger, T., Englund, E., Gelpi, E., Giese, A., Irwin, D. J., Meissner, W. G., Pantelyat, A., Rajput, A., van Swieten, J. C., Troakes, C. & 27 othersAntonini, A., Bhatia, K. P., Bordelon, Y., Compta, Y., Corvol, J-C., Colosimo, C., Dickson, D. W., Dodel, R., Ferguson, L., Grossman, M., Kassubek, J., Krismer, F., Levin, J., Lorenzl, S., Morris, H. R., Nestor, P., Oertel, W. H., Poewe, W., Rabinovici, G. D., Rowe, J. B., Schellenberg, G. D., Seppi, K., van Eimeren, T., Wenning, G. K., Boxer, A. L., Golbe, L. I. & Litvan, I., 2017, In : Movement Disorders. 32, 6, p. 853-864

    Research output: Contribution to journalArticle

  12. PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins

    Perez-Soriano, A., Arena, J. E., Dinelle, K., Miao, Q., McKenzie, J., Neilson, N., Andreas Puschmann, Schaffer, P., Shinotoh, H., Smith-Forrester, J., Shahinfard, E., Vafai, N., Wile, D., Wszolek, Z. K., Higuchi, M., Sossi, V. & Stoessl, A. J., 2017, In : Movement Disorders. 32, 7, p. 1016-1024

    Research output: Contribution to journalArticle

  13. 2016
  14. Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression

    Majbour, N. K., Nishant N. Vaikath, Eusebi, P., Chiasserini, D., Ardah, M., Varghese, S., Haque, M. E., Tokuda, T., Auinger, P., Calabresi, P., Parnetti, L. & El-Agnaf, O. M. A., 2016 Oct 1, In : Movement Disorders. 31, 10, p. 1535-1542 8 p.

    Research output: Contribution to journalArticle

  15. Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease

    Malek, N., Lawton, M. A., Swallow, D. M. A., Grosset, K. A., Marrinan, S. L., Bajaj, N., Barker, R. A., Burn, D. J., Hardy, J., Morris, H. R., Williams, N. M., Wood, N., Ben-Shlomo, Y., Grosset, D. G. & PRoBaND Clinical Consortium, 2016 Oct, In : Movement Disorders. 31, 10, p. 1518-1526 9 p.

    Research output: Contribution to journalArticle

  16. Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia

    Abdelnour, C., van Steenoven, I., Elisabet Londos, Blanc, F., Auestad, B., Kramberger, M. G., Zetterberg, H., Mollenhauer, B., Boada, M. & Aarsland, D., 2016 Aug 1, In : Movement Disorders. 31, 8, p. 1203-1208 6 p.

    Research output: Contribution to journalArticle

  17. Time on timing: Dissociating premature responding from interval sensitivity in Parkinson's disease

    Zhang, J., Nombela, C., Wolpe, N., Barker, R. A. & Rowe, J. B., 2016 Aug, In : Movement Disorders. 31, 8, p. 1163-72 10 p.

    Research output: Contribution to journalArticle

  18. Aberrant nigral diffusion in Parkinson's disease: A longitudinal diffusion tensor imaging study

    Loane, C., Politis, M., Kefalopoulou, Z., Valle-Guzman, N., Gesine Paul, Håkan Widner, Foltynie, T., Barker, R. A. & Piccini, P., 2016 Jul, In : Movement Disorders. 31, 7, p. 1020-6

    Research output: Contribution to journalArticle

  19. Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease

    Breen, D. P., Nombela, C., Vuono, R., Jones, P. S., Fisher, K., Burn, D. J., Brooks, D. J., Reddy, A. B., Rowe, J. B. & Barker, R. A., 2016 Jul, In : Movement Disorders. 31, 7, p. 1062-6 5 p.

    Research output: Contribution to journalArticle

  20. Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)

    Williams-Gray, C. H., Wijeyekoon, R., Yarnall, A. J., Lawson, R. A., Breen, D. P., Evans, J. R., Cummins, G. A., Duncan, G. W., Khoo, T. K., Burn, D. J., Barker, R. A. & ICICLE-PD Study Group, 2016 Jul, In : Movement Disorders. 31, 7, p. 995-1003 9 p.

    Research output: Contribution to journalArticle

  21. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?

    Duncan, G. W., Firbank, M. J., Yarnall, A. J., Khoo, T. K., Brooks, D. J., Barker, R. A., Burn, D. J. & O'Brien, J. T., 2016 Jan, In : Movement Disorders. 31, 1, p. 103-10 8 p.

    Research output: Contribution to journalArticle

  22. Heterozygous PINK1 p.G411S mutation increases risk for Parkinson's disease (PD)

    Springer, W., Puschmann, A., Fiesel, F. C., Ando, M., Caulfield, T. R., Ogaki, K., Heckman, M. G., Hudec, R., James, E. D., Opala, G., Siuda, J., Boczarska-Jedynak, M., Friedman, A., Koziorowski, D., Aasly, J. O., Lynch, T., Mellick, G. D., Mohan, M., Silburn, P. A., Sanotsky, Y. & 5 othersVilariño-Güell, C., Farrer, M. J., Dawson, T. M., Wszolek, Z. K. & Ross, O. A., 2016, In : Movement Disorders. 31, Suppl. S2, p. S282 1 p.

    Research output: Contribution to journalPublished meeting abstract

  23. Integrated Safety of Levodopa-Carbidopa Intestinal Gel From Prospective Clinical Trials.

    Lang, A. E., Rodriguez, R. L., Boyd, J. T., Chouinard, S., Zadikoff, C., Espay, A. J., Slevin, J. T., Fernandez, H. H., Lew, M. F., Stein, D. A., Odin, P., Fung, V. S. C., Klostermann, F., Fasano, A., Draganov, P. V., Schmulewitz, N., Robieson, W. Z., Eaton, S., Chatamra, K., Benesh, J. A. & 1 othersDubow, J., 2016, In : Movement Disorders. 31, 4, p. 538-546

    Research output: Contribution to journalArticle

  24. Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.

    Sara Hall, Yulia Surova, Öhrfelt, A., Blennow, K., Zetterberg, H. & Oskar Hansson, 2016, In : Movement Disorders.

    Research output: Contribution to journalArticle

  25. On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats.

    Carta, M. & Angela Cenci Nilsson, 2016, In : Movement Disorders. 31, 1, p. 149

    Research output: Contribution to journalLetter

  26. 2015
  27. EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease

    Martinez-Martin, P., Reddy, P., Katzenschlager, R., Antonini, A., Todorova, A., Odin, P., Henriksen, T., Martin, A., Calandrella, D., Rizos, A., Bryndum, N., Glad, A., Dafsari, H. S., Timmermann, L., Ebersbach, G., Kramberger, M. G., Samuel, M., Wenzel, K., Tomantschger, V., Storch, A. & 7 othersReichmann, H., Pirtosek, Z., Trost, M., Svenningsson, P., Palhagen, S., Volkmann, J. & Chaudhuri, K. R., 2015, In : Movement Disorders. 30, 4, p. 510-516

    Research output: Contribution to journalArticle

  28. King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation.

    Chaudhuri, K. R., Rizos, A., Trenkwalder, C., Rascol, O., Pal, S., Martino, D., Carroll, C., Paviour, D., Falup-Pecurariu, C., Kessel, B., Silverdale, M., Todorova, A., Sauerbier, A., Per Odin, Antonini, A. & Martinez-Martin, P., 2015, In : Movement Disorders. 30, 12, p. 1623-1631

    Research output: Contribution to journalArticle

  29. Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Final 12-Month, Open-Label Results

    Fernandez, H. H., Standaert, D. G., Hauser, R. A., Lang, A. E., Fung, V. S. C., Klostermann, F., Lew, M. F., Per Odin, Steiger, M., Yakupov, E. Z., Chouinard, S., Suchowersky, O., Dubow, J., Hall, C. M., Chatamra, K., Robieson, W. Z., Benesh, J. A. & Espay, A. J., 2015, In : Movement Disorders. 30, 4, p. 500-509

    Research output: Contribution to journalArticle

  30. 2014
  31. Neuroacanthocytosis - Clinical variability (a report on six cases)

    Dulski, J., Soltan, W., Schinwelski, M., Sitek, E. J., Rudzinska, M., Wójcik-Pedziwiatr, M., Wictor, L., Schön, F., A. Puschmann, Klempir, J., Tilley, L., Roth, J., Tacik, P., Fujioka, S., Traynor, S., Wszolek, Z. K., Drozdowski, W. & Slawek, J., 2014 May 1, In : Movement Disorders. 29, Suppl 1, p. S194 517.

    Research output: Contribution to journalPublished meeting abstract

  32. The spectrum of cognitive impairment in Lewy body diseases

    Goldman, J. G., Williams-Gray, C., Barker, R. A., Duda, J. E. & Galvin, J. E., 2014 Apr 15, In : Movement Disorders. 29, 5, p. 608-21 14 p.

    Research output: Contribution to journalReview article

  33. Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms

    Duncan, G. W., Khoo, T. K., Yarnall, A. J., O'Brien, J. T., Coleman, S. Y., Brooks, D. J., Barker, R. A. & Burn, D. J., 2014 Feb, In : Movement Disorders. 29, 2, p. 195-202 8 p.

    Research output: Contribution to journalArticle

  34. Alpha-Synuclein Repeat Variants and Survival in Parkinson's Disease

    Chung, S. J., Biernacka, J. M., Armasu, S. M., Anderson, K., Frigerio, R., Aasly, J. O., Annesi, G., Bentivoglio, A. R., Brighina, L., Chartier-Harlin, M-C., Goldwurm, S., Hadjigeorgiou, G., Jasinska-Myga, B., Jeon, B. S., Kim, Y. J., Krueger, R., Lesage, S., Markopoulou, K., Mellick, G., Morrison, K. E. & 9 othersAndreas Puschmann, Tan, E-K., Crosiers, D., Theuns, J., Van Broeckhoven, C., Wirdefeldt, K., Wszolek, Z. K., Elbaz, A. & Maraganore, D. M., 2014, In : Movement Disorders. 29, 8, p. 1053-1057

    Research output: Contribution to journalArticle

  35. Flt3 ligand does not differentiate between Parkinsonian disorders.

    Silajdzic, E., Constantinescu, R., Holmberg, B., Maria Björkqvist & Oskar Hansson, 2014, In : Movement Disorders. 29, 10, p. 1319-1322

    Research output: Contribution to journalArticle

  36. Plasma Melatonin Is Reduced in Huntington's Disease

    Kalliolia, E., Silajdzic, E., Nambron, R., Hill, N. R., Doshi, A., Frost, C., Watt, H., Hindmarsh, P., Maria Björkqvist & Warner, T. T., 2014, In : Movement Disorders. 29, 12, p. 1511-1515

    Research output: Contribution to journalArticle

  37. 2013
  38. Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies

    Bezard, E., Yue, Z., Deniz Kirik & Spillantini, M. G., 2013, In : Movement Disorders. 28, 1, p. 61-70

    Research output: Contribution to journalReview article

  39. Cell therapy for Parkinson's disease: what next?

    Anders Björklund & Kordower, J. H., 2013, In : Movement Disorders. 28, 1, p. 110-115

    Research output: Contribution to journalArticle

  40. Developing dopaminergic cell therapy for Parkinson's disease-give up or move forward?

    Olle Lindvall, 2013, In : Movement Disorders. 28, 3, p. 268-273

    Research output: Contribution to journalDebate/Note/Editorial

  41. Future falls and/or near falls in people with Parkinson’s disease: Sensitivity and specificity of two retropulsion tests

    Beata Lindholm, Oskar Hansson, Duzynski, W., Maria H Nilsson & Hagell, P., 2013, In : Movement Disorders. 28(S1), p. 163-163

    Research output: Contribution to journalPublished meeting abstract

  42. Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?

    Olanow, C. W. & Brundin, P., 2013, In : Movement Disorders. 28, 1, p. 31-40

    Research output: Contribution to journalReview article

  43. Population-specific Frequencies for LRRK2 Susceptibility Variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium

    Heckman, M. G., Soto-Ortolaza, A. I., Aasly, J. O., Abahuni, N., Annesi, G., Bacon, J. A., Bardien, S., Bozi, M., Brice, A., Brighina, L., Carr, J., Chartier-Harlin, M-C., Dardiotis, E., Dickson, D. W., Diehl, N. N., Elbaz, A., Ferrarese, C., Fiske, B., Gibson, J. M., Gibson, R. & 42 othersHadjigeorgiou, G. M., Hattori, N., Ioannidis, J. P. A., Boczarska-Jedynak, M., Jasinska-Myga, B., Jeon, B. S., Kim, Y. J., Klein, C., Kruger, R., Kyratzi, E., Lesage, S., Lin, C-H., Lynch, T., Maraganore, D. M., Mellick, G. D., Mutez, E., Nilsson, C., Opala, G., Park, S. S., Petrucci, S., Andreas Puschmann, Quattrone, A., Sharma, M., Silburn, P. A., Sohn, Y. H., Stefanis, L., Tadic, V., Theuns, J., Tomiyama, H., Uitti, R. J., Valente, E. M., Van Broeckhoven, C., van de Loo, S., Vassilatis, D. K., Vilarino-Gueell, C., White, L. R., Wirdefeldt, K., Wszolek, Z. K., Wu, R-M., Hentati, F., Farrer, M. J. & Ross, O. A., 2013, In : Movement Disorders. 28, 12, p. 1740-1744

    Research output: Contribution to journalArticle

  44. Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia

    Bezard, E., Tronci, E., Pioli, E. Y., Li, Q., Porras, G., Anders Björklund & Carta, M., 2013, In : Movement Disorders. 28, 8, p. 1088-1096

    Research output: Contribution to journalArticle

  45. Trophic Factor Gene Therapy for Parkinson's Disease

    Kordower, J. H. & Anders Björklund, 2013, In : Movement Disorders. 28, 1, p. 96-109

    Research output: Contribution to journalReview article

  46. Variability in Neuronal Expression of Dopamine Receptors and Transporters in the Substantia Nigra

    Reyes, S., Cottam, V., Deniz Kirik, Double, K. L. & Halliday, G. M., 2013, In : Movement Disorders. 28, 10, p. 1351-1359

    Research output: Contribution to journalArticle

  47. 2011
  48. Graft-Induced Dyskinesias in Parkinson's Disease: High Striatal Serotonin/Dopamine Transporter Ratio

    Politis, M., Oertel, W. H., Wu, K., Quinn, N. P., Pogarell, O., Brooks, D. J., Anders Björklund, Olle Lindvall & Piccini, P., 2011, In : Movement Disorders. 26, 11, p. 1997-2003

    Research output: Contribution to journalArticle

  49. 2010
  50. LRRK2 variation and Parkinson's disease in African Americans

    Ross, O. A., Wilhoite, G. J., Bacon, J. A., Soto-Ortolaza, A. I., Kachergus, J., Cobb, S. A., Andreas Puschmann, Vilariño-Güell, C., Farrer, M. J., Graff-Radford, N. R., Meschia, J. F. & Wszolek, Z. K., 2010 Sep 15, In : Movement Disorders. 25, 12, p. 1973-1992 20 p.

    Research output: Contribution to journalArticle

  51. Characterization of Lewy Body Pathology in 12-and 16-Year Old Intrastriatal Mesencephalic Grafts Surviving in a Patient with Parkinson's Disease

    Jia-Yi Li, Englund, E., Håkan Widner, Rehncrona, S., Anders Björklund, Olle Lindvall & Brundin, P., 2010, In : Movement Disorders. 25, p. S629-S630

    Research output: Contribution to journalPublished meeting abstract

  52. Current Evidence of PD Nursing: Where Do We Go from Here?

    Hagell, P., 2010, In : Movement Disorders. 25, p. S589-S589

    Research output: Contribution to journalPublished meeting abstract

  53. Fatigue Rating Scales Critique and Recommendations by the Movement Disorders Society Task Force on Rating Scales for Parkinson's Disease

    Friedman, J. H., Alves, G., Hagell, P., Marinus, J., Marsh, L., Martinez-Martin, P., Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. & Schrag, A., 2010, In : Movement Disorders. 25, 7, p. 805-822

    Research output: Contribution to journalReview article

  54. Gene Therapy

    Deniz Kirik, 2010, In : Movement Disorders. 25, p. S604-S604

    Research output: Contribution to journalPublished meeting abstract

  55. Gene therapy for Parkinson's disease.

    Tomas Björklund & Kordower, J. H., 2010, In : Movement Disorders. 25 Suppl 1, p. S161-S173

    Research output: Contribution to journalArticle

Previous 1 2 Next